NYLIM
AMED

New York Life Investment Management’s Amedisys AMED Stock Holding History

New York Life Investment Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-76,931
Closed -$7.09M – 875
2024
Q1 		$7.09M Sell
76,931
-17,061
-18% -$1.6M 0.07% 246
2023
Q4 		$8.93M Buy
93,992
+17,149
+22% +$1.6M 0.09% 194
2023
Q3 		$7.18M Buy
76,843
+43,385
+130% +$4.01M 0.08% 234
2023
Q2 		$3.06M Buy
+33,458
New +$2.74M 0.03% 412

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

New York Life Investment Management's AMED Position: Q2 2024 in Review

New York Life Investment Management sold out of Amedisys (AMED) in Q2 2024, closing a stake of 76,931 shares — an estimated $7.09M sold.

New York Life Investment Management first reported a position in AMED in Q2 2023 and held it in 4 quarters. The position peaked at $8.93M in Q4 2023. 289 funds tracked by Wall St. Rank hold AMED as of Q2 2024.

  • New York Life Investment Management reported no remaining Amedisys position as of Q2 2024 after selling out during the quarter.
  • New York Life Investment Management sold 76,931 Amedisys shares in Q2 2024, an estimated $7.09M.
  • New York Life Investment Management first reported a position in Amedisys in Q2 2023 and held it in 4 quarters.
  • New York Life Investment Management's Amedisys position peaked at $8.93M in Q4 2023.
  • 289 funds tracked by Wall St. Rank held Amedisys as of Q2 2024.

Based on New York Life Investment Management's 13F filing for Q2 2024, filed 5 Aug 2024.